首页> 外文期刊>Intensivmedizin und Notfallmedizin >Intensivmedizinische Betreuung von Patienten nach Stammzelltransplantation
【24h】

Intensivmedizinische Betreuung von Patienten nach Stammzelltransplantation

机译:干细胞移植后患者的重症监护

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Within the hematologic therapy procedures, stem cell transplantation (SCT) represents the most extensive and invasive intervention. Those patients have certain risks for several bacterial, viral, as well as fungal infections during the different stages of transplantation. Especially in allogenic transplantation, discrimination of non-infectious, mostly immunologic complications like graft-versus-host reactions or VOD (veno-occlusive disease) is crucial, and often represents a therapeutic challenge. An adequate intensive care therapy of these patients can only be achieved with the knowledge of the specific complications of SCT. This review starts with an overview of the SCT stages with their corresponding infectious and noninfectious complications, followed by the discussion of organ specific pulmonary, renal, cardiac, gastrointestinal, hepatic and neurological complications of stem cell transplantation.
机译:在血液治疗程序中,干细胞移植(SCT)代表了最广泛的侵入性干预措施。这些患者在移植的不同阶段中有几种细菌,病毒以及真菌感染的风险。特别是在同种异体移植中,对非传染性,主要是免疫性并发症(如移植物抗宿主反应或VOD(静脉闭塞性疾病))的辨别至关重要,通常代表治疗挑战。只有了解SCT的具体并发症,才能对这些患者进行充分的重症监护治疗。这篇综述首先概述了SCT阶段及其相应的感染性和非感染性并发症,然后讨论了干细胞移植的器官特异性肺,肾,心脏,胃肠道,肝和神经系统并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号